Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNA5 | P22460 | 4/20 | 0.36 |
| ▸ | MAOA | P21397 | 4/20 | 0.34 |
| ▸ | BCHE | P06276 | 1/20 | 0.34 |
| ▸ | ACHE | P22303 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.33 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.33 |
| ▸ | KCNJ5 | P48544 | 1/20 | 0.33 |
| ▸ | KCNJ3 | P48549 | 1/20 | 0.33 |
| ▸ | PLK1 | P53350 | 1/20 | 0.33 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.33 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.33 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.33 |
| ▸ | MAOB | P27338 | 2/20 | 0.33 |
| ▸ | PDE10A | Q9Y233 | 2/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21592291 | 0.88 | KMT2A (0.35) | KCNA5ALDH1A1KCNJ5KCNJ3CYP11B1 | |
| SCHEMBL21592282 | 0.85 | CYP11B1 (0.40) | KCNA5BCHEACHEKCNJ5KCNJ3 | |
| SCHEMBL21592285 | 0.84 | KCNA5 (0.36) | KCNA5ALDH1A1KCNJ5KCNJ3CYP11B1 | |
| SCHEMBL21591545 | 0.84 | SMN1; SMN2 (0.33) | KCNA5ALDH1A1NPSR1KDM4E | |
| SCHEMBL21592278 | 0.80 | POLB (0.38) | KCNA5ALDH1A1KCNJ5KCNJ3CYP11B1 | |
| SCHEMBL21591444 | 0.78 | CYP11B1 (0.42) | ALDH1A1CYP11B1CYP11B2KDM4E | |
| SCHEMBL21591551 | 0.78 | MEN1 (0.33) | NPSR1KDM4E | |
| SCHEMBL21591434 | 0.77 | CYP11B1 (0.39) | ALDH1A1CYP11B1CYP11B2KDM4E | |
| SCHEMBL21591431 | 0.76 | CYP11B1 (0.48) | ALDH1A1NPSR1CYP11B1CYP11B2MAOB | |
| SCHEMBL31361796 | 0.74 | FNTA (0.33) | ALDH1A1NPSR1CYP11B1CYP11B2KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220402898-A1 | MODULATORS OF STIMULATOR OF INTERFERON GENES (STING) | Ryvu Therapeutics S.A. (PL) | 2022-12-22 | — | — | US | disclosed |
| WO-2019238786-A1 | MODULATORS OF STIMULATOR OF INTERFERON GENES (STING) | Ryvu Therapeutics S.A. (PL) | 2019-12-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220402898-A1 | MODULATORS OF STIMULATOR OF INTERFERON GENES (STING) | STING1, IRF3, CGAS | KCNA5 2592/4885MAOA 747/4885BCHE 4622/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.